RSV is a highly-contagious virus that causes inflammation in the lower airways.
While most people recover in a few weeks, RSV can be serious. Infants and older adults are most likely to develop severe RSV symptoms that may require hospitalization. The immunizations were developed to provide needed protection against the dangerous and sometimes life-threatening virus.
RSV symptoms
- Difficulty breathing
- Wheezing
- Runny nose
- Decreased appetite
- Coughing
- Fever
Vaccine recommendations
-
Adults ages 75 and older should receive one dose of the vaccine.
-
Adults ages 60-74 at an increased risk of severe RSV should receive one dose of the vaccine.
-
Pregnant women can receive one dose of the maternal RSV vaccine during weeks 32 through 36 of pregnancy. It should be administered between September and January.
-
Infants younger than 8 months of age and who were born shortly before or are entering their first RSV season can receive one dose of nirsevimab, a monoclonal antibody product that is considered a passive immunization.
-
Infants aged 8 – 19 months at an increased risk of severe RSV disease and entering their second RSV season can receive one dose of nirsevimab.
For pregnant women, adults 60-74 and adults 75 and older who received an RSV vaccine last year, you are not eligible to receive a dose this year.
Learn more about the Centers for Disease Control and Prevention (CDC) RSV vaccine recommendations.
Schedule your RSV vaccine
To schedule your RSV vaccine, contact your health care provider.
Talk to your insurance carrier before receiving your RSV immunization
Coverage may change depending on your insurance carrier. Patients are encouraged to call to discuss coverage options prior to making an appointment to receive their vaccine.
